Elagolix: a promising oral GnRH antagonist for endometriosis-associated pain

Oncotarget. 2017 Nov 11;8(59):99219-99220. doi: 10.18632/oncotarget.22381. eCollection 2017 Nov 21.

Authors

Erica C Dun¹, Hugh S Taylor¹

Affiliation

¹ Hugh S. Taylor: Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale School of Medicine, New Haven, Connecticut, USA.

No abstract available

Keywords: GnRH antagonist; elagolix; endometriosis; endometriosis-related pain.

Publication types

Editorial

Grants and funding

UL1 TR001863/TR/NCATS NIH HHS/United States